Document Detail


Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial.
MedLine Citation:
PMID:  12527665     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To investigate the effects of a 12 week comprehensive cardiac rehabilitation (CCR) programme on patients who have undergone implantation of an implantable cardioverter-defibrillator (ICD).
DESIGN: Sixteen patients with ICDs (14 (88%) male, mean (SD) age 58 (10) years, range 34-74 years) were randomised to either attend an individually tailored CCR programme or receive usual care. They then changed to the alternative regimen for a further 12 weeks. Exercise capacity was assessed using a treadmill exercise test at baseline, after usual care, after CCR and 12 weeks after CCR to assess maintenance effects. Hospital anxiety and depression (HAD) scores were recorded at each stage.
RESULTS: Exercise times (min:s; mean (SD)) increased by 16% from a baseline mean of 9:55 (2:33) to 11:11 (2:17) following attendance at CCR (95% confidence interval (CI) 0:34 to 1:58; p = 0.001). This improvement was maintained 12 weeks after attendance at CCR, at 11:20 (2:17) (p = 1.00). HAD scores for anxiety and depression decreased during CCR from a baseline of 13.4 (3.6) to 8.1 (3.6), 95% CI 3.5 to 7.0 (p < 0.001) and 9.9 (3.4) to 6.7 (2.9), 95% CI 1.9 to 4.4 (p = 0.002), respectively. These improvements were maintained at 12 weeks after CCR. No ventricular arrhythmias or ICD discharges occurred during the exercise components of the CCR. The total number of ventricular arrhythmias and ICD discharges was similar 12 weeks before, during, and 12 weeks after CCR.
CONCLUSIONS: CCR appears to be safe for patients with ICDs. It can improve exercising ability and lower the levels of psychological distress. A larger multicentre study is recommended to confirm these findings.
Authors:
A Fitchet; P J Doherty; C Bundy; W Bell; A P Fitzpatrick; C J Garratt
Related Documents :
18003075 - Development of tilt table with visual feedback function for hemiplegia patients.
17558245 - The enduring impact of social factors on exercise tolerance in men attending cardiac re...
1590645 - Multivariate models for compliance with phase 3 cardiac rehabilitation services in joha...
15893685 - Exercise and rehabilitation for individuals with multiple sclerosis.
11395765 - Stability of atmospheric co2 levels across the triassic/jurassic boundary.
12502075 - Risk to breeding success of fish-eating ardeids due to persistent organic contaminants ...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Heart (British Cardiac Society)     Volume:  89     ISSN:  1468-201X     ISO Abbreviation:  Heart     Publication Date:  2003 Feb 
Date Detail:
Created Date:  2003-01-15     Completed Date:  2003-03-07     Revised Date:  2013-06-09    
Medline Journal Info:
Nlm Unique ID:  9602087     Medline TA:  Heart     Country:  England    
Other Details:
Languages:  eng     Pagination:  155-60     Citation Subset:  AIM; IM    
Affiliation:
Manchester Heart Centre, Manchester Royal Infirmary, Manchester, UK. alan.fitchet@talk21.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Anxiety / etiology
Arrhythmias, Cardiac / physiopathology,  prevention & control,  psychology
Defibrillators, Implantable*
Depression / etiology
Exercise / physiology
Exercise Test
Exercise Therapy / methods
Female
Heart Diseases / physiopathology,  psychology,  rehabilitation*
Humans
Male
Middle Aged
Program Evaluation
Prospective Studies
Ventricular Dysfunction, Left / physiopathology
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced...
Next Document:  Mitral annular calcification: a marker of severe coronary artery disease in patients under 65 years ...